Literature Review

Pipeline shield with single antiplatelet therapy in aneurysmal subarachnoid haemorrhage: multicentre experience

Background

The Pipeline embolisation Device with shield technology (PED-shield) is suggested to have reduced thrombogenicity. This reduced thrombogenicity may make it possible to use safely in the acute treatment of aneurysmal subarachnoid haemorrhage (aSAH) on single antiplatelet therapy (SAPT).

Objective

To evaluate the safety and efficacy of the off-label use of PED-shield with SAPT for the acute treatment of aSAH.